Steven A. Curley, MD

Steven Curley

Title: Professor of Surgery
Company: Baylor College of Medicine
Location: Houston, Texas, United States

Steven A. Curley, MD, Professor of Surgery at Baylor College of Medicine, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in medicine and higher education.

An esteemed figure in the medical and education industries, Dr. Curley has accrued nearly 30 years of experience in his fields of interest. Since January 2014, he has served as a Chief and Professor of Surgical Oncology at Baylor College of Medicine, simultaneously working as an Oncology Service Line Medical Director at the CHI St. Luke’s Health-Baylor St. Luke’s Medical Center since 2015. Prior to his current appointments, he was a faculty member rising to the rank of professor of surgical oncology at the University of Texas MD Anderson Cancer Center from 1988 to 2013, and soon thereafter, was promoted to the Charles B. Barker Endowed Chair in Surgery. Dr. Curley has also served as an adjunct professor of the Department of Mechanical Engineering and Material Sciences at Rice University.

In preparation for his lauded career, Dr. Curley first sought formal education, graduating with a Bachelor of Science in biology and chemistry from the University of New Mexico in 1978. He subsequently earned a Doctor of Medicine at the University of Texas in 1982. Thereafter, he completed a residency in general surgery at several hospitals affiliated with the University of New Mexico from 1982 to 1988, as well as a fellowship at the University of Texas MD Anderson Cancer Center in 1988. He is certified by the American Board of Surgery.

As a leading expert in the medical community, Dr. Curley maintains affiliation with several industry-related organizations, including the Society of Surgical Oncology, the American College of Surgeons, and the American Society of Clinical Oncology. He is also a member of the Society for Surgery of the Alimentary Tract, the Southwest Oncology Group, America’s Hepato-Pancreato-Biliary Association, and the American Surgical Association.

Among his numerous achievements, Dr. Curley prides himself on being the developer of two FDA-approved devices for invasive radiofrequency ablation needles to treat unresectable liver cancers in 2001. In addition, in 1999, he wrote a paper which was the most surgically-cited paper in the world for the next three years. In recognition of his exceptional accomplishments, Dr. Curley was named among the Top 1 Percent of Physicians by the U.S. News & World Report LLP from 2012 to 2015, and he has been named one of America’s Top Doctors by Castle Connolly.

Furthermore, Dr. Curley has been presented with several accolades throughout his career. The winner of the Tribeca Disruptive Innovator Award in 2012, he was also presented with the Outstanding Teacher Award by the University of Texas MD Anderson Cancer Center in 2011, the Patients’ Choice Award by America’s Most Compassionate Doctors between 2010 and 2015, and listed in America’s Top Doctors for Cancer Database from 2005 to 2017. Looking toward the future, Dr. Curley aspires to continue saving the lives of his patients while making a positive impact upon his colleagues and students alike.

For more:


Press Release

Industry Leaders

Dr. Steven Curley’s Blog

Contact Dr. Curley

Leave a Reply